Clinical Trials in North Carolina

Showing 2681-2700 of 17,526 trials

Telehealth-Enhanced Assessment and Management

NCT06247254

TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.

Blood Pressure

Wake Forest University Health Sciences86 participantsStarted Nov 2024

Winston-Salem, North Carolina, United States

RECRUITING41 miles

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

NCT02855476

HDClarity will seek at least 2500 research participants at different stages of Huntington's disease (HD). The primary objective is to collect a high quality CSF sample for evaluation of biomarkers and pathways that will enable the development of novel treatments for HD. The secondary objective is to generate a high quality plasma sample collection matching the CSF collections, which will also be used to evaluate biomarkers and pathways of relevance to HD research and development.

Huntington's Disease

University College, London2,500 participantsStarted Jan 2017

Englewood, Colorado, United States • Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States +36 more locations

Telehealth-Enhanced Assessment and Management

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Find Trials by Condition in North Carolina

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Feasibility of a Train-the-Trainer Delivered Exercise Intervention in Firefighters

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

Pancreatic Cancer Detection Consortium

Blue Light Cystoscopy With Cysview® Registry

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

C.Difficile Observational Study

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Validating Innovative Biosensors for Rett Autonomic Symptom Tracking

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System